Crystal Crop Protection IPO GMP Today – Live Grey Market Premium
As of 13 Nov 2026, 4:12 PM IST, Crystal Crop Protection IPO GMP is ₹45, a 16.5% premium over the ₹272 upper price band, which points to an estimated listing price of about ₹317. Kostak: not available. Subject to Sauda: not available.
Crystal Crop Protection IPO is scheduled to open for subscription on November 18, 2026. The public issue aims to raise around ₹455.49 Cr. and is offered in a price band of ₹259 to ₹272 per share, with a market lot of TBA shares. The day-wise GMP trend is below.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 13 Nov, 4:12 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 13 Nov 2026 | ₹ 45 | — | 16.54% | — | — |
Crystal Crop Protection IPO dates
Key dates from opening to listing. Today is 13 November.
- Open 18 Nov 2026
- Close 20 Nov 2026
- Allotment TBA
- Refund/credit TBA
- Listing 26 Nov 2026
Crystal Crop Protection IPO expected listing price
Upper price band plus today's grey market premium.
| Issue price (upper band) | ₹272 |
|---|---|
| Current GMP | ₹ 45 |
| Listing date | 26 Nov, 2026 |
| GMP-based listing estimate | ₹317 (+16.5%) |
Disclaimer: The listing price estimate above is based purely on the current grey market premium (GMP) and is not a guaranteed prediction. GMP is an unofficial, unregulated indicator and can change significantly in the 24–48 hours before listing. Do not make investment decisions based solely on GMP.
Is Crystal Crop Protection IPO GMP reliable?
Grey market premium for Crystal Crop Protection IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Crystal Crop Protection IPO full review for a fundamentals-based assessment before making any grey market trades.
Crystal Crop Protection IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Crystal Crop Protection IPO is not available. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price is not available. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Crystal Crop Protection IPO
Crystal Crop Protection Limited was set up in 1994 as Jai Bharat Crop Chemical Private Limited. It became a public limited company in 2018. The company describes itself as a crop solutions company with agrochemicals and seeds at the core of its offerings. Its registered office is in Ahmedabad and its corporate office is in New Delhi.
The crop protection range covers herbicides, fungicides and insecticides. It also covers natural crop solutions such as bio-stimulants, bio-protectants, plant growth regulators, liquid fertilizers and micro nutrients. This business gave Rs 1,515.61 crore, or 77.82% of revenue from operations, in the six months ended 30 September 2025. In FY2025 it gave 81.74%.
The seeds business covers field crops, vegetable crops and flowers. It gave 21.59% of revenue in the six months ended 30 September 2025, against 12.66% in FY2023. The company bought I&B Seeds in October 2024, so FY2025 includes only five months of that business.
The company runs six manufacturing units for crop protection. Four are formulation units: two in Jammu, one in Sonipat and one in Anand. Two are technical manufacturing units, in Nagpur and Dahej. It also has a technical pilot unit in Sonipat and has bought land for a new plant in Jhagadia, Gujarat. Seeds are processed at two units, in Hyderabad and Bengaluru.
Research is done at the Key Research Development Centre in Sonipat, with field research stations across several states. The business is mainly domestic. India gave 97.48% of revenue from operations in FY2025 and international sales gave 1.72%. Raw materials are bought from domestic suppliers and from suppliers in China, mostly on purchase orders.
Frequently asked
What is the GMP of Crystal Crop Protection IPO?
The current Grey Market Premium (GMP) of Crystal Crop Protection IPO is ₹ 45.
What is the Kostak Price of Crystal Crop Protection IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Crystal Crop Protection IPO is not available.
What is the Subject to Sauda Price of Crystal Crop Protection IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What is the expected listing price of Crystal Crop Protection IPO based on GMP?
Based on the current GMP of ₹ 45, Crystal Crop Protection IPO is expected to list around ₹317 — approximately +16.5% above the issue price of ₹272. Grey market prices can shift before listing — treat this as an estimate only.
Is the GMP of Crystal Crop Protection IPO increasing or decreasing?
The GMP of Crystal Crop Protection IPO is currently stable. Track the day-wise GMP table above for the latest movement.
Explore Crystal Crop Protection IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
Price band, lot size, financials, objects of the issue and promoters.
Category-wise demand from QIB, NII and retail investors, updated through the day.
Before the book opens, see what analysts make of it.
Check with your PAN whether shares were credited to your demat account.
GMP is a mood, not a forecast.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
